Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,563 | -88,093 | -60,735 | -41,721 | -19,575 |
| Depreciation Amortization | -629 | -1,749 | -1,056 | -1,000 | -657 |
| Income taxes - deferred | N/A | -681 | -681 | -681 | -681 |
| Accounts receivable | -446 | -675 | -301 | 223 | 37 |
| Accounts payable and accrued liabilities | -1,187 | 2,506 | 4,593 | 640 | 866 |
| Other Working Capital | -1,991 | 6,752 | 3,134 | -399 | 73 |
| Other Operating Activity | 5,874 | 14,405 | 6,959 | 6,748 | 3,097 |
| Operating Cash Flow | $-20,942 | $-67,535 | $-48,087 | $-36,190 | $-16,840 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -3,669 | -132,462 | -53,305 | 96,016 | -5,101 |
| PPE Investments | -21 | -11 | -10 | -10 | N/A |
| Investing Cash Flow | $-3,690 | $-132,473 | $-53,315 | $96,006 | $-5,101 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 35,000 | 15,000 | 15,000 | N/A |
| Common Stock Issued | 79,257 | 174,065 | 112,420 | 72,749 | 34,918 |
| Other Financing Activity | -784 | -2,223 | -1,708 | -1,386 | -799 |
| Financing Cash Flow | $78,473 | $206,842 | $125,712 | $86,363 | $34,119 |
| Beginning Cash Position | 43,802 | 36,968 | 36,968 | 36,968 | 36,968 |
| End Cash Position | 97,643 | 43,802 | 61,278 | 183,147 | 49,146 |
| Net Cash Flow | $53,841 | $6,834 | $24,310 | $146,179 | $12,178 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,942 | -67,535 | -48,087 | -36,190 | -16,840 |
| Capital Expenditure | -21 | -11 | -10 | -10 | N/A |
| Free Cash Flow | -20,963 | -67,546 | -48,097 | -36,200 | -16,840 |